These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12133406)

  • 1. [Loss of heterozygosity at chromosome 3p14, 25 in serum DNA from ovarian cancer patients].
    Zhang H; Li Z; Chen M; Zhang G; Xu K
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):298-300. PubMed ID: 12133406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
    Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
    Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma: from the Danish "MALOVA" Ovarian Carcinoma Study.
    Høgdall EV; Ryan A; Kjaer SK; Blaakaer J; Christensen L; Bock JE; Glud E; Jacobs IJ; Høgdall CK
    Cancer; 2004 Jun; 100(11):2387-95. PubMed ID: 15160342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The loss of heterozygosity on the short arm of chromosome 3 in renal carcinoma].
    Maestro de las Casas ML; del Barco Barriuso V; Moreno Sierra J; Izquierdo López L; Sanz Casla MT; Zanna I; Redondo González E; Chicharro Almarza J; Fernández Pérez C; Resel Estévez L
    Arch Esp Urol; 1999; 52(1):3-9. PubMed ID: 10101881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity at chromosome 3p in epithelial ovarian cancer in China.
    Zhang GL; Xu KL
    Int J Gynecol Cancer; 2002; 12(2):198-201. PubMed ID: 11975680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease.
    Trimeche M; Braham H; Ziadi S; Amara K; Hachana M; Korbi S
    Oral Oncol; 2008 Aug; 44(8):775-83. PubMed ID: 18206419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
    Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients.
    Hickey KP; Boyle KP; Jepps HM; Andrew AC; Buxton EJ; Burns PA
    Br J Cancer; 1999 Aug; 80(11):1803-8. PubMed ID: 10468300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
    Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
    Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
    Schwarzenbach H; Müller V; Stahmann N; Pantel K
    Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic changes associated with ovarian cancer.
    Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
    Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Precise map of allelic loss on chromosome 3p14 in nasopharyngeal carcinoma].
    Deng Y; Tian F; Yang X; Xie D; Lu Y; Shao X; Chen Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Oct; 35(5):391-3. PubMed ID: 12768747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma.
    Goessl C; Heicappell R; Münker R; Anker P; Stroun M; Krause H; Müller M; Miller K
    Cancer Res; 1998 Oct; 58(20):4728-32. PubMed ID: 9788629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy.
    Kozlowski L; Filipowski T; Rucinska M; Pepinski W; Janica J; Skawronska M; Poznanski J; Wojtukiewicz MZ
    Neoplasma; 2006; 53(5):440-3. PubMed ID: 17013540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xp22.2-3 loss of heterozygosity is associated with germline BRCA1 mutation in ovarian cancer.
    Buekers TE; Lallas TA; Buller RE
    Gynecol Oncol; 2000 Mar; 76(3):418-22. PubMed ID: 10684722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent FHIT gene loss of heterozygosity in human papillomavirus-infected non-smoking female lung cancer in Taiwan.
    Wang J; Cheng YW; Wu DW; Chen JT; Chen CY; Chou MC; Lee H
    Cancer Lett; 2006 Apr; 235(1):18-25. PubMed ID: 15935551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.